Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
Massimino M, Vennarini S, Buttarelli FR, Antonelli M, Colombo F, Minasi S, Pecori E, Ferroli P, Giussani C, Schiariti M, Schiavello E, Biassoni V, Erbetta A, Chiapparini L, Nigro O, Boschetti L, Gianno F, Miele E, Modena P, De Cecco L, Pollo B, Barretta F. Massimino M, et al. Among authors: de cecco l. J Neurooncol. 2023 Jul;163(3):577-586. doi: 10.1007/s11060-023-04361-z. Epub 2023 Jun 16. J Neurooncol. 2023. PMID: 37326761
Case report: biallelic DNMT3A mutations in acute myeloid leukemia.
Cumbo C, Orsini P, Anelli L, Zagaria A, Iannò MF, De Cecco L, Minervini CF, Coccaro N, Tota G, Parciante E, Conserva MR, Redavid I, Tarantini F, Minervini A, Carluccio P, De Grassi A, Pierri CL, Specchia G, Musto P, Albano F. Cumbo C, et al. Among authors: de cecco l, de grassi a. Front Oncol. 2023 Jun 28;13:1205220. doi: 10.3389/fonc.2023.1205220. eCollection 2023. Front Oncol. 2023. PMID: 37448520 Free PMC article.
A gene expression-based classifier for HER2-low breast cancer.
Di Cosimo S, Pizzamiglio S, Ciniselli CM, Duroni V, Cappelletti V, De Cecco L, De Marco C, Silvestri M, De Santis MC, Vingiani A, Paolini B, Orlandi R, Iorio MV, Pruneri G, Verderio P. Di Cosimo S, et al. Among authors: de santis mc, de cecco l, de marco c. Sci Rep. 2024 Feb 1;14(1):2628. doi: 10.1038/s41598-024-52148-7. Sci Rep. 2024. PMID: 38297001 Free PMC article.
Impact of in vitro SARS-CoV-2 infection on breast cancer cells.
Sommariva M, Dolci M, Triulzi T, Ambrogi F, Dugo M, De Cecco L, Le Noci V, Bernardo G, Anselmi M, Montanari E, Pupa SM, Signorini L, Gagliano N, Sfondrini L, Delbue S, Tagliabue E. Sommariva M, et al. Among authors: de cecco l. Sci Rep. 2024 Jun 7;14(1):13134. doi: 10.1038/s41598-024-63804-3. Sci Rep. 2024. PMID: 38849411 Free PMC article.
Widening the spectrum of players affected by genetic changes in Wilms tumor relapse.
Ciceri S, Bertolotti A, Serra A, Gattuso G, Boschetti L, Capasso M, Cecchi C, Sorrentino S, Quarello P, Ciniselli CM, Verderio P, De Cecco L, Manenti G, Diomedi Camassei F, Collini P, Spreafico F, Perotti D. Ciceri S, et al. Among authors: de cecco l. iScience. 2024 Aug 6;27(9):110684. doi: 10.1016/j.isci.2024.110684. eCollection 2024 Sep 20. iScience. 2024. PMID: 39262773 Free PMC article.
Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors.
Minna E, Devecchi A, Pistore F, Paolini B, Mauro G, Penso DA, Pagliardini S, Busico A, Pruneri G, De Cecco L, Borrello MG, Sensi M, Greco A. Minna E, et al. Among authors: de cecco l. Front Endocrinol (Lausanne). 2023 Oct 5;14:1267499. doi: 10.3389/fendo.2023.1267499. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37867524 Free PMC article.
Claudin-1 in Head and Neck Squamous Cell Carcinoma.
Cavalieri S, Bergamini C, Lenoci D, Ottini A, Lucchetta M, Torchia E, Licitra L, De Cecco L. Cavalieri S, et al. Among authors: de cecco l. Oncology. 2024 Aug 14:1-5. doi: 10.1159/000540775. Online ahead of print. Oncology. 2024. PMID: 39231459 Free article.
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.
Forlani L, De Cecco L, Simeon V, Paolini B, Bagnoli M, Cecere SC, Spina A, Citeroni E, Bignotti E, Lorusso D, Arenare L, Russo D, De Angelis C, Ardighieri L, Scognamiglio G, Del Sesto M, Tognon G, Califano D, Schettino C, Chiodini P, Perrone F, Mezzanzanica D, Pignata S, Tomassetti A. Forlani L, et al. Among authors: de cecco l, de angelis c. J Exp Clin Cancer Res. 2023 Apr 11;42(1):83. doi: 10.1186/s13046-023-02651-y. J Exp Clin Cancer Res. 2023. PMID: 37041632 Free PMC article.
288 results